United States · FDA National Drug Code directory
Levothyroxine Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71335-1814_09f4bc22-a7e4-481f-940b-4e5340c5ae98
- Product NDC
- 71335-1814
- Form
- TABLET
- Composition / generic term
- Levothyroxine Sodium
- Labeler
- Bryant Ranch Prepack
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20200803
- Source listing expiry
- 20271231
Source-listed ingredients
- LEVOTHYROXINE SODIUM — 100 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET in 1 BOTTLE (71335-1814-0) · 71335-1814-0
- 100 TABLET in 1 BOTTLE (71335-1814-1) · 71335-1814-1
- 30 TABLET in 1 BOTTLE (71335-1814-2) · 71335-1814-2
- 60 TABLET in 1 BOTTLE (71335-1814-3) · 71335-1814-3
- 7 TABLET in 1 BOTTLE (71335-1814-4) · 71335-1814-4
- 14 TABLET in 1 BOTTLE (71335-1814-5) · 71335-1814-5
- 90 TABLET in 1 BOTTLE (71335-1814-6) · 71335-1814-6
- 28 TABLET in 1 BOTTLE (71335-1814-7) · 71335-1814-7
- 56 TABLET in 1 BOTTLE (71335-1814-8) · 71335-1814-8
- 180 TABLET in 1 BOTTLE (71335-1814-9) · 71335-1814-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →